Rupak Pathak
Concepts (244)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosome Aberrations | 7 | 2022 | 317 | 2.610 |
Why?
| Radiation Injuries | 7 | 2022 | 149 | 2.380 |
Why?
| Thrombomodulin | 4 | 2020 | 41 | 2.320 |
Why?
| Vitamin E | 7 | 2021 | 112 | 2.070 |
Why?
| Human Umbilical Vein Endothelial Cells | 4 | 2022 | 92 | 1.590 |
Why?
| Radiation, Ionizing | 8 | 2022 | 121 | 1.380 |
Why?
| Tocotrienols | 4 | 2019 | 46 | 1.330 |
Why?
| Chromans | 4 | 2021 | 66 | 1.330 |
Why?
| DNA Damage | 7 | 2021 | 360 | 1.270 |
Why?
| Methionine | 3 | 2021 | 148 | 1.050 |
Why?
| Mice | 27 | 2024 | 6464 | 1.050 |
Why?
| Bone Marrow Cells | 5 | 2021 | 229 | 1.040 |
Why?
| Intestines | 5 | 2022 | 203 | 1.010 |
Why?
| Animals | 35 | 2024 | 14777 | 0.960 |
Why?
| In Situ Hybridization, Fluorescence | 3 | 2024 | 274 | 0.960 |
Why?
| Chromosomes | 1 | 2024 | 39 | 0.950 |
Why?
| Radiation-Protective Agents | 4 | 2021 | 118 | 0.910 |
Why?
| Intestine, Small | 2 | 2021 | 125 | 0.900 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2020 | 39 | 0.870 |
Why?
| Mosaicism | 1 | 2022 | 18 | 0.840 |
Why?
| Translocation, Genetic | 3 | 2019 | 289 | 0.830 |
Why?
| Spleen | 2 | 2020 | 194 | 0.820 |
Why?
| Intestinal Diseases | 2 | 2019 | 37 | 0.800 |
Why?
| Chromosome Painting | 3 | 2019 | 9 | 0.800 |
Why?
| Radiation Protection | 1 | 2021 | 55 | 0.800 |
Why?
| Duodenum | 1 | 2021 | 40 | 0.790 |
Why?
| Jejunum | 1 | 2021 | 61 | 0.780 |
Why?
| Ileum | 1 | 2021 | 102 | 0.770 |
Why?
| Proteome | 1 | 2022 | 173 | 0.760 |
Why?
| Spectral Karyotyping | 2 | 2019 | 9 | 0.760 |
Why?
| Weightlessness Simulation | 1 | 2020 | 24 | 0.750 |
Why?
| Thymus Gland | 1 | 2020 | 48 | 0.740 |
Why?
| Gamma Rays | 1 | 2020 | 59 | 0.740 |
Why?
| DNA | 1 | 2024 | 597 | 0.730 |
Why?
| Mice, Inbred C57BL | 15 | 2022 | 2013 | 0.720 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2020 | 82 | 0.710 |
Why?
| Chromosome Breakpoints | 1 | 2019 | 7 | 0.700 |
Why?
| Malnutrition | 1 | 2021 | 91 | 0.700 |
Why?
| Particulate Matter | 2 | 2016 | 55 | 0.700 |
Why?
| Simvastatin | 1 | 2019 | 34 | 0.670 |
Why?
| Abdominal Neoplasms | 1 | 2019 | 20 | 0.670 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 155 | 0.660 |
Why?
| Pelvic Neoplasms | 1 | 2019 | 21 | 0.660 |
Why?
| Thrombosis | 1 | 2021 | 257 | 0.650 |
Why?
| Lymphocytes | 2 | 2022 | 171 | 0.630 |
Why?
| Whole-Body Irradiation | 7 | 2021 | 163 | 0.630 |
Why?
| Hematopoietic Stem Cells | 5 | 2017 | 206 | 0.620 |
Why?
| DNA Probes | 2 | 2017 | 35 | 0.620 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 431 | 0.610 |
Why?
| Plant Extracts | 1 | 2019 | 197 | 0.560 |
Why?
| Cell Culture Techniques | 1 | 2016 | 110 | 0.550 |
Why?
| Hematopoiesis | 2 | 2017 | 83 | 0.540 |
Why?
| Blood Cells | 2 | 2015 | 53 | 0.540 |
Why?
| Recombinant Proteins | 1 | 2016 | 540 | 0.500 |
Why?
| Dose-Response Relationship, Radiation | 6 | 2020 | 209 | 0.490 |
Why?
| Carrier Proteins | 2 | 2014 | 367 | 0.490 |
Why?
| Gene Expression Regulation | 7 | 2020 | 1075 | 0.480 |
Why?
| Oxidative Stress | 6 | 2017 | 949 | 0.480 |
Why?
| Chromosomes, Human | 1 | 2014 | 45 | 0.470 |
Why?
| Apoptosis | 5 | 2017 | 1299 | 0.440 |
Why?
| Chromosome Banding | 2 | 2024 | 27 | 0.420 |
Why?
| Oxygen | 3 | 2021 | 359 | 0.400 |
Why?
| Cytogenetics | 2 | 2022 | 26 | 0.390 |
Why?
| Humans | 17 | 2024 | 54581 | 0.390 |
Why?
| Radioisotopes | 2 | 2007 | 18 | 0.370 |
Why?
| DNA Methylation | 4 | 2020 | 584 | 0.340 |
Why?
| Heavy Ions | 2 | 2015 | 17 | 0.330 |
Why?
| Male | 21 | 2022 | 27656 | 0.330 |
Why?
| Dose-Response Relationship, Drug | 5 | 2020 | 1529 | 0.320 |
Why?
| Gastrointestinal Tract | 3 | 2022 | 128 | 0.320 |
Why?
| Radiation Injuries, Experimental | 3 | 2020 | 113 | 0.300 |
Why?
| DNA Repair | 2 | 2021 | 209 | 0.300 |
Why?
| Lithium Compounds | 1 | 2007 | 12 | 0.300 |
Why?
| Oxygen Radioisotopes | 1 | 2007 | 16 | 0.300 |
Why?
| Intestinal Mucosa | 2 | 2021 | 258 | 0.300 |
Why?
| Carbon Radioisotopes | 1 | 2007 | 54 | 0.300 |
Why?
| Protein Binding | 3 | 2021 | 710 | 0.290 |
Why?
| Metaphase | 3 | 2016 | 49 | 0.290 |
Why?
| Lithium | 1 | 2007 | 43 | 0.290 |
Why?
| Cytogenetic Analysis | 2 | 2024 | 87 | 0.290 |
Why?
| Macrophages | 3 | 2021 | 407 | 0.290 |
Why?
| Long Interspersed Nucleotide Elements | 2 | 2017 | 41 | 0.290 |
Why?
| Mice, Inbred CBA | 3 | 2021 | 41 | 0.280 |
Why?
| Lasers | 1 | 2007 | 136 | 0.280 |
Why?
| Dietary Supplements | 2 | 2020 | 463 | 0.280 |
Why?
| Cell Line | 3 | 2016 | 1139 | 0.280 |
Why?
| Radiation Tolerance | 2 | 2019 | 94 | 0.280 |
Why?
| Cells, Cultured | 4 | 2016 | 1731 | 0.270 |
Why?
| Epigenesis, Genetic | 3 | 2022 | 399 | 0.260 |
Why?
| Fluorescent Dyes | 2 | 2017 | 117 | 0.250 |
Why?
| Radiation Dosage | 3 | 2021 | 178 | 0.250 |
Why?
| Antioxidants | 2 | 2016 | 288 | 0.240 |
Why?
| Mitochondria | 2 | 2022 | 469 | 0.240 |
Why?
| Metabolome | 2 | 2014 | 100 | 0.220 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 152 | 0.210 |
Why?
| Monocytes | 2 | 2021 | 156 | 0.210 |
Why?
| Reactive Oxygen Species | 2 | 2022 | 485 | 0.210 |
Why?
| Karyotyping | 1 | 2022 | 94 | 0.210 |
Why?
| Rodentia | 1 | 2022 | 22 | 0.200 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2021 | 48 | 0.200 |
Why?
| Primates | 1 | 2021 | 23 | 0.200 |
Why?
| Gene Expression | 2 | 2015 | 662 | 0.200 |
Why?
| Macaca mulatta | 1 | 2021 | 108 | 0.200 |
Why?
| HEK293 Cells | 2 | 2019 | 236 | 0.200 |
Why?
| Body Weight | 2 | 2020 | 584 | 0.200 |
Why?
| DNA Breaks, Double-Stranded | 3 | 2016 | 78 | 0.190 |
Why?
| Catecholamines | 1 | 2020 | 51 | 0.190 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2020 | 5 | 0.190 |
Why?
| Radiation | 1 | 2020 | 17 | 0.180 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2020 | 71 | 0.180 |
Why?
| Survival Analysis | 2 | 2019 | 713 | 0.180 |
Why?
| Abdomen | 1 | 2020 | 86 | 0.180 |
Why?
| Drinking | 1 | 2020 | 82 | 0.180 |
Why?
| Disease Models, Animal | 4 | 2019 | 1653 | 0.180 |
Why?
| Acute Radiation Syndrome | 1 | 2020 | 23 | 0.180 |
Why?
| Proteomics | 1 | 2022 | 332 | 0.180 |
Why?
| Flow Cytometry | 3 | 2017 | 536 | 0.170 |
Why?
| Protons | 2 | 2017 | 84 | 0.170 |
Why?
| Energy Intake | 1 | 2020 | 193 | 0.170 |
Why?
| Stress, Physiological | 1 | 2020 | 192 | 0.170 |
Why?
| Stem Cells | 2 | 2017 | 193 | 0.170 |
Why?
| Garlic | 1 | 2019 | 7 | 0.170 |
Why?
| Bone Resorption | 1 | 2022 | 336 | 0.170 |
Why?
| Ascorbic Acid | 1 | 2019 | 28 | 0.170 |
Why?
| Curcumin | 1 | 2019 | 18 | 0.170 |
Why?
| Neoplasms | 2 | 2020 | 1346 | 0.170 |
Why?
| Gene Rearrangement | 1 | 2019 | 86 | 0.170 |
Why?
| Time Factors | 5 | 2016 | 3223 | 0.160 |
Why?
| Osteoclasts | 1 | 2022 | 475 | 0.160 |
Why?
| Up-Regulation | 2 | 2016 | 499 | 0.150 |
Why?
| Mice, Transgenic | 3 | 2016 | 639 | 0.150 |
Why?
| Fibrinogen | 1 | 2017 | 36 | 0.150 |
Why?
| Occupational Exposure | 1 | 2019 | 130 | 0.150 |
Why?
| Micronucleus Tests | 2 | 2007 | 9 | 0.150 |
Why?
| Cell Separation | 2 | 2016 | 100 | 0.150 |
Why?
| RNA, Messenger | 3 | 2020 | 1231 | 0.150 |
Why?
| Inflammation | 1 | 2021 | 679 | 0.150 |
Why?
| Cricetulus | 2 | 2007 | 103 | 0.150 |
Why?
| Lung | 3 | 2016 | 523 | 0.150 |
Why?
| Cricetinae | 2 | 2007 | 215 | 0.140 |
Why?
| DNA Fragmentation | 2 | 2007 | 69 | 0.140 |
Why?
| Peroxidase | 1 | 2016 | 18 | 0.140 |
Why?
| Diet | 1 | 2021 | 601 | 0.140 |
Why?
| Neutrophil Infiltration | 1 | 2016 | 29 | 0.140 |
Why?
| Drug Synergism | 1 | 2016 | 168 | 0.140 |
Why?
| Recombinational DNA Repair | 1 | 2015 | 9 | 0.140 |
Why?
| DNA Repair Enzymes | 1 | 2016 | 50 | 0.140 |
Why?
| Peroxynitrous Acid | 2 | 2013 | 47 | 0.140 |
Why?
| PTEN Phosphohydrolase | 1 | 2016 | 59 | 0.130 |
Why?
| Myeloproliferative Disorders | 1 | 2016 | 29 | 0.130 |
Why?
| Female | 6 | 2022 | 28520 | 0.130 |
Why?
| Homologous Recombination | 1 | 2015 | 42 | 0.130 |
Why?
| Transforming Growth Factor beta | 1 | 2016 | 162 | 0.130 |
Why?
| Endodeoxyribonucleases | 1 | 2015 | 55 | 0.130 |
Why?
| Metabolomics | 2 | 2014 | 132 | 0.130 |
Why?
| Genomic Instability | 1 | 2015 | 92 | 0.130 |
Why?
| Endothelium | 1 | 2015 | 46 | 0.130 |
Why?
| Signal Transduction | 2 | 2020 | 1733 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 664 | 0.130 |
Why?
| Collagen | 1 | 2016 | 228 | 0.130 |
Why?
| Cell Survival | 2 | 2007 | 676 | 0.120 |
Why?
| Models, Animal | 1 | 2015 | 268 | 0.120 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2014 | 25 | 0.120 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2014 | 27 | 0.120 |
Why?
| DNA Helicases | 1 | 2015 | 145 | 0.120 |
Why?
| Gene Order | 1 | 2013 | 18 | 0.110 |
Why?
| Gene Targeting | 1 | 2013 | 32 | 0.110 |
Why?
| Leukocyte Count | 1 | 2013 | 76 | 0.110 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 38 | 0.110 |
Why?
| Microscopy, Fluorescence | 1 | 2014 | 189 | 0.110 |
Why?
| Linear Energy Transfer | 2 | 2015 | 17 | 0.110 |
Why?
| Leukemia | 1 | 2013 | 71 | 0.110 |
Why?
| Mice, Knockout | 1 | 2015 | 938 | 0.100 |
Why?
| Rats, Sprague-Dawley | 1 | 2016 | 1784 | 0.100 |
Why?
| MicroRNAs | 1 | 2016 | 381 | 0.100 |
Why?
| Liver Cirrhosis | 1 | 2014 | 218 | 0.100 |
Why?
| Glutathione | 1 | 2013 | 338 | 0.100 |
Why?
| Cytokines | 1 | 2015 | 691 | 0.100 |
Why?
| Models, Biological | 1 | 2013 | 809 | 0.090 |
Why?
| Rats | 1 | 2016 | 3660 | 0.090 |
Why?
| Histones | 3 | 2016 | 335 | 0.080 |
Why?
| Mutation | 1 | 2015 | 1420 | 0.080 |
Why?
| Liver | 1 | 2014 | 1227 | 0.080 |
Why?
| Blood Cell Count | 2 | 2017 | 43 | 0.070 |
Why?
| Radiotherapy Dosage | 1 | 2007 | 256 | 0.070 |
Why?
| Cell Death | 1 | 2007 | 227 | 0.070 |
Why?
| MAP Kinase Signaling System | 2 | 2016 | 131 | 0.070 |
Why?
| Lipid Metabolism | 2 | 2014 | 187 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 48 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 17 | 0.050 |
Why?
| Permeability | 1 | 2022 | 86 | 0.050 |
Why?
| Tight Junctions | 1 | 2019 | 29 | 0.040 |
Why?
| Transcriptome | 1 | 2020 | 349 | 0.040 |
Why?
| Retroelements | 1 | 2017 | 15 | 0.040 |
Why?
| Energy Metabolism | 1 | 2020 | 305 | 0.040 |
Why?
| Species Specificity | 1 | 2017 | 216 | 0.040 |
Why?
| Fibrosis | 1 | 2017 | 213 | 0.040 |
Why?
| Azacitidine | 1 | 2016 | 37 | 0.040 |
Why?
| Neurofibromin 1 | 1 | 2016 | 13 | 0.030 |
Why?
| DNA End-Joining Repair | 1 | 2015 | 14 | 0.030 |
Why?
| Arkansas | 1 | 2022 | 2172 | 0.030 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 70 | 0.030 |
Why?
| Blood Glucose | 1 | 2019 | 487 | 0.030 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 100 | 0.030 |
Why?
| DNA, Satellite | 1 | 2015 | 13 | 0.030 |
Why?
| Interleukin-13 | 1 | 2015 | 17 | 0.030 |
Why?
| ras Proteins | 1 | 2016 | 68 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 108 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2015 | 119 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2016 | 131 | 0.030 |
Why?
| Epigenomics | 1 | 2015 | 67 | 0.030 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 169 | 0.030 |
Why?
| Cell Cycle | 1 | 2016 | 276 | 0.030 |
Why?
| Cell Movement | 1 | 2016 | 266 | 0.030 |
Why?
| Escherichia coli Proteins | 1 | 2015 | 103 | 0.030 |
Why?
| Hematologic Neoplasms | 1 | 2016 | 99 | 0.030 |
Why?
| Myeloid Cells | 1 | 2014 | 38 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2016 | 249 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 201 | 0.030 |
Why?
| Iron | 1 | 2015 | 157 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 2014 | 133 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2014 | 130 | 0.030 |
Why?
| Mitosis | 1 | 2014 | 112 | 0.030 |
Why?
| Citrulline | 1 | 2014 | 101 | 0.030 |
Why?
| Membrane Proteins | 1 | 2016 | 379 | 0.030 |
Why?
| Insulin | 1 | 2016 | 503 | 0.030 |
Why?
| Phthalazines | 1 | 2013 | 20 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 99 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2013 | 241 | 0.030 |
Why?
| Cluster Analysis | 1 | 2013 | 258 | 0.030 |
Why?
| Piperazines | 1 | 2013 | 120 | 0.030 |
Why?
| Acute Disease | 1 | 2013 | 413 | 0.030 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 5 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 31 | 0.020 |
Why?
| Risk Factors | 1 | 2020 | 3915 | 0.020 |
Why?
| Fibroblasts | 1 | 2013 | 373 | 0.020 |
Why?
| Biological Availability | 1 | 2010 | 133 | 0.020 |
Why?
| Nitric Oxide Synthase | 1 | 2010 | 102 | 0.020 |
Why?
| Indoles | 1 | 2013 | 290 | 0.020 |
Why?
| Obesity | 1 | 2019 | 1177 | 0.020 |
Why?
| Random Allocation | 1 | 2010 | 317 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2010 | 431 | 0.020 |
Why?
| Endothelium, Vascular | 1 | 2010 | 287 | 0.020 |
Why?
| Endothelial Cells | 1 | 2010 | 293 | 0.020 |
Why?
|
|
Pathak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|